Future studies may be needed to test the potency and safety of CasRx-based anti-KrasG12D using other murine G12D Kras pancreatic cancer cell lines or in an immunocompetent mice such as the KPC mice 31, 32. The gene discussed is KRAS; the disease is pancreatic neoplasm.